26780-50-7
26780-50-7
Chemical Structure
Poly(D,L-lactide-co-glycolide)
- CAS No.: 26780-50-7
- Formula:N/A
- Molecular Weight:N/A
SMILES: CC(C(OCC(OC)=O)=O)C.[m].[n]
Biological Activity: Poly(D,L-lactide-co-glycolide) is a biodegradable polymer copolymer. Poly(D,L-lactide-co-glycolide) undergoes degradation through ester bond hydrolysis into lactic acid and glycolic acid. These two products can be naturally eliminated through metabolism in the body (such as the tricarboxylic acid cycle), without the risk of long-term accumulation. Poly(D,L-lactide-co-glycolide) can be used in medical sutures, implants, and drug delivery systems[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Poly(D,L-lactide-co-glycolide) | Poly(D,L-lactide-co-glycolide) is a biodegradable polymer copolymer. Poly(D,L-lactide-co-glycolide) undergoes degradation through ester bond hydrolysis into lactic acid and glycolic acid. These two products can be naturally eliminated through metabolism in the body (such as the tricarboxylic acid cycle), without the risk of long-term accumulation. Poly(D,L-lactide-co-glycolide) can be used in medical sutures, implants, and drug delivery systems. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Poly(D,L-lactide-co-glycolide), 65:35 | Poly(D,L-lactide-co-glycolide), 65:35 (PGCL, 65:35) is a copolymer formed by the ring-opening polymerization of lactide and glycolide, which can be used for drug delivery. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Poly(D,L-lactide-co-glycolide), 75:25 | Poly(D,L-lactide-co-glycolide), 75:25 (PGCL, 75:25) is a copolymer formed by the ring-opening polymerization of lactide and glycolide, which can be used for drug delivery. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Poly(D,L-lactide-co-glycolide), 50:50 | Poly(D,L-lactide-co-glycolide), 50:50 (PGCL, 50:50) is a copolymer formed by the ring-opening polymerization of lactide and glycolide, which can be used for drug delivery. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Aranda A, et al. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol In Vitro. 2013 Mar;27(2):954-63. [Content Brief]
- [2]. Holgado MA, et al. Possibilities of poly(D,L-lactide-co-glycolide) in the formulation of nanomedicines against cancer. Curr Drug Targets. 2011 Jul 1;12(8):1096-111. [Content Brief]
- [3]. Lima AF, et al. Poly(d,l-lactide-co-glycolide) (PLGA) Nanoparticles Loaded with Proteolipid Protein (PLP)-Exploring a New Administration Route. Polymers (Basel). 2020 Dec 21;12(12):3063. [Content Brief]
